Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
ROWLAND LLOYD A
General Counsel at CytomX Therapeutics. Filing since 4 Mar 2019.
CIK 0001236395
Company
Date
Role
Action
Shares
Amount
Of holding
CTMX
CytomX Therapeutics, Inc.
18 Mar 2025
General Counsel
Sold at will
10,203
$6.11K
7.8%
CTMX
CytomX Therapeutics, Inc.
20 Aug 2024
General Counsel
Sold at will
4,181
$5.14K
3.1%
CTMX
CytomX Therapeutics, Inc.
19 Mar 2024
General Counsel
Sold at will
5,268
$10.99K
4.3%
CTMX
CytomX Therapeutics, Inc.
20 Dec 2023
General Counsel
Sold at will
4,077
$5.63K
4.0%
CTMX
CytomX Therapeutics, Inc.
22 Sep 2023
General Counsel
Sold at will
5,486
$7.14K
6.4%
CTMX
CytomX Therapeutics, Inc.
16 Mar 2023
General Counsel
Sold at will
2,037
$4.03K
2.8%
CTMX
CytomX Therapeutics, Inc.
20 Jul 2022
General Counsel
Sold, plan not stated
5,602
$7.97K
11.4%
CTMX
CytomX Therapeutics, Inc.
4 Mar 2019
General Counsel
Bought
9,000
$92.97K
919%
8 decisions on file.
